| 1 | “We are not invited”: Australian focus group results on how to improve ethnic diversity in trials | 2.5 | 23 | Citations (PDF) |
| 2 | A collaborative approach to adopting/adapting guidelines. The Australian 24-hour movement guidelines for children (5-12 years) and young people (13-17 years): An integration of physical activity, sedentary behaviour, and sleep | 3.8 | 132 | Citations (PDF) |
| 3 | The Cochrane Library | 3.3 | 55 | Citations (PDF) |
| 4 | The Cochrane Library | 3.3 | 6 | Citations (PDF) |
| 5 | Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement | 20.0 | 238 | Citations (PDF) |
| 6 | 919Step-by-step guidance on prospective meta-analyses | 3.0 | 0 | Citations (PDF) |
| 7 | The Cochrane Library | 3.3 | 12 | Citations (PDF) |
| 8 | Selecting, refining and identifying priority Cochrane Reviews in health communication and participation in partnership with consumers and other stakeholders | 1.8 | 33 | Citations (PDF) |
| 9 | Extending the RIGHT statement for reporting adapted practice guidelines in healthcare: the RIGHT-Ad@pt Checklist protocol | 1.3 | 18 | Citations (PDF) |
| 10 | The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures | 4.0 | 234 | Citations (PDF) |
| 11 | Research priorities in health communication and participation: international survey of consumers and other stakeholders | 1.3 | 58 | Citations (PDF) |
| 12 | Sharing and reuse of individual participant data from clinical trials: principles and recommendations | 1.3 | 156 | Citations (PDF) |
| 13 | A collaborative approach to adopting/adapting guidelines - The Australian 24-Hour Movement Guidelines for the early years (Birth to 5 years): an integration of physical activity, sedentary behavior, and sleep | 2.2 | 323 | Citations (PDF) |
| 14 | GRADE: Assessing the quality of evidence in environmental and occupational health | 6.7 | 243 | Citations (PDF) |
| 15 | Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation | 0.2 | 9,874 | Citations (PDF) |
| 16 | Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement | 4.0 | 19,683 | Citations (PDF) |
| 17 | The Cochrane Library | 3.3 | 65 | Citations (PDF) |
| 18 | Bumps and bridges on the road to responsible sharing of clinical trial data | 1.3 | 24 | Citations (PDF) |
| 19 | Increasing value and reducing waste: addressing inaccessible research | 49.6 | 723 | Citations (PDF) |
| 20 | The Quality of Registration of Clinical Trials: Still a Problem | 1.6 | 124 | Citations (PDF) |
| 21 | PROSPERO at one year: an evaluation of its utility | 4.0 | 152 | Citations (PDF) |
| 22 | Information on blinding in registered records of clinical trials | 1.2 | 7 | Citations (PDF) |
| 23 | The nuts and bolts of PROSPERO: an international prospective register of systematic reviews | 4.0 | 1,151 | Citations (PDF) |
| 24 | The ClinicalTrials.gov Results Database | 25.2 | 9 | Citations (PDF) |
| 25 | Pharmacokinetic research in children: an analysis of registered records of clinical trials | 1.3 | 16 | Citations (PDF) |
| 26 | The Quality of Registration of Clinical Trials | 1.6 | 129 | Citations (PDF) |
| 27 | Establishing a Minimum Dataset for Prospective Registration of Systematic Reviews: An International Consultation | 1.6 | 59 | Citations (PDF) |
| 28 | From Mexico to Mali: four years in the history of clinical trial registration | 1.5 | 61 | Citations (PDF) |
| 29 | Post-operative radiotherapy for ductal carcinoma in situ of the breast – A systematic review of the randomised trials | 0.9 | 47 | Citations (PDF) |
| 30 | Sustaining hope when communicating with terminally ill patients and their families: a systematic review | 2.3 | 260 | Citations (PDF) |
| 31 | Reporting the findings of clinical trials: a discussion paper. | 1.6 | 31 | Citations (PDF) |
| 32 | Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review | 3.1 | 351 | Citations (PDF) |
| 33 | The Cochrane Library | 3.3 | 0 | Citations (PDF) |
| 34 | A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. | 0.6 | 427 | Citations (PDF) |
| 35 | Discrepant Perceptions About End-of-Life Communication: A Systematic Review | 0.6 | 124 | Citations (PDF) |
| 36 | A proposed protocol for the development of a register of trials of weight management of childhood overweight and obesity | 3.1 | 8 | Citations (PDF) |
| 37 | Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer | 15.4 | 91 | Citations (PDF) |
| 38 | The Cochrane Library | 3.3 | 15 | Citations (PDF) |
| 39 | Chemotherapy or Endocrine Therapy for Metastatic Breast Cancer? | 1.9 | 8 | Citations (PDF) |
| 40 | The Cochrane Library | 3.3 | 85 | Citations (PDF) |
| 41 | Making It Happen: Approaches to Involving Consumers in Cochrane Reviews | 1.2 | 15 | Citations (PDF) |
| 42 | Scientific background and rationale for a randomised controlled trial | 1.5 | 1 | Citations (PDF) |
| 43 | Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer | 6.2 | 170 | Citations (PDF) |
| 44 | Randomized double-blind trial of beta-carotene and vitamin C in women with minor cervical abnormalities | 4.5 | 53 | Citations (PDF) |
| 45 | The Cochrane Library | 3.3 | 105 | Citations (PDF) |
| 46 | The Cochrane Library | 3.3 | 36 | Citations (PDF) |
| 47 | A guide to prospective meta-analysis | 0.1 | 97 | Citations (PDF) |
